Epidemiology, Screening, and Pretreatment Evaluation of the Patient With Chronic Hepatitis C Infection

Chronic hepatitis C is the most common blood-borne pathogen, affecting approximately 3% of the world’s population. In the United States, approximately 75% of the disease burden of hepatitis C is found in the 25% of the population born between 1945 and 1965. The slowly progressive disease leads to co...

Full description

Saved in:
Bibliographic Details
Published in:Journal for nurse practitioners 2015-01, Vol.11 (1), p.109-115
Main Authors: Gardenier, Donald, Kwong, Jeffrey, Olson, Mary C., Epstein, Rachel
Format: Article
Language:English
Subjects:
blood-borne pathogen
Chronic illnesses
cirrhosis
Drug use
Epidemiology
Genotype & phenotype
Hepatitis
hepatitis C
Hepatitis C virus
hepatocellular carcinoma
HIV
Human immunodeficiency virus
Infections
Laboratories
Liver cancer
Liver diseases
Medical research
Mortality
Risk factors
screening
Substance abuse treatment
Ultrasonic imaging
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Chronic hepatitis C is the most common blood-borne pathogen, affecting approximately 3% of the world’s population. In the United States, approximately 75% of the disease burden of hepatitis C is found in the 25% of the population born between 1945 and 1965. The slowly progressive disease leads to complications after years of infection in a majority of cases, and because of disparate prevalence, a high burden of disease is expected over the next 10-15 years. Previous treatments for hepatitis C had poor efficacy and tolerability and have not led to a significant reduction in projected disease burden. Newer treatments are more effective, better tolerated, and are changing the approach to chronic hepatitis C. Nurse practitioners are expected to continue to play key roles in the care of this patient population.
ISSN:1555-4155
1878-058X
DOI:10.1016/j.nurpra.2014.10.015